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ABSTRA CT
The aim: O f th is study was to analyze ep idem io logical data on th e  de tection o f im m unog lobu lins o f  class M and G (IgM , IgG) to  SARS-CoV-2 am ong urban and rural population 
o f Poltava region.
Materials and methods: We have analyzed the  research results o f  2841 patients to  de te rm ine IgM and IgG levels to  SARS-CoV-2. The s tudy included th e  results o f  patients in 
Poltava and nearby villages o f  Poltava region, obta ined during Ju ly -  December 2020.
Results: Thus, 84%  o f patients applied fo r detection o f  IgM in the  serum o f patients w ith  the  pathogen C0VID-2019. We have found on ly  135 positive results fo r th e  detection 
o f IgM to  SARS-CoV-2, which was 5.7%  o f the  to ta l num ber o f  people w ho  underw ent th is study from  July to December 2020. Moreover, wom en received a positive result more 
often than men. The IP samples fo r the  detection o f IgM to SARS-CoV-2 in the serum o f patients averaged 2.5 ±  1.04.
It was found th a t patients w en t to the  laboratory to detect IgG to SARS-CoV-2 w ith  the  vast m a jo rity  am ong them  were residents o f  Poltava. However, in th is  case th e  share o f  
positive results was 47.7% , among which the  fem ale population ou tnum bered the  male.
Conclusions: The frequency o f detection o f positive results on IgM to SARS-CoV-2 is about 6% . The share o f positive resultson IgG to  SARS-CoV-2 was 47.7%, am ong them  76.2%  
were wom en. The frequency o f  detection o f  IgM and IgG to  SARS-CoV-2 during October-December 2020 sign ifican tly  exceeds the  indices in Ju ly-Septem ber o f  the  same year.
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IN T R O D U C T IO N
Coronaviruses (CoVs) are a group of complex viruses that are 
characterized by high mutation rates and infectivity. They are 
zoonotic pathogens that affect both animals (wild/domestic) 
and humans, followed by the development of acute respiratory 
syndrome in about 10% of cases [1, 2]. Previously, corona- 
viruses were not included in the list of dangerous human 
pathogens. However, at the beginning of the 21st century, two 
members of this virus family -  SARS-CoV and MERS-CoV 
caused global epidemics of pneumonia with a high mortality 
rate [1, 3]. Moreover, 7 years after the last outbreak of the 
coronavirus epidemic (2012) humanity faced a rapid spread 
of cases of severe atypical pneumonia caused by a new strain 
of coronavirus SARS-CoV-2 in December 2019 [4].
Up to now, according to the WHO, about 6 million peo­
ple in more than 210 countries have been exposed to the 
disease caused by this pathogen -  COVID-2019 [5]. The 
mortality rate for this disease is not much higher than for 
SARS-CoV and MERS-CoV. However, the new pathogen 
is characterized by higher infectivity and contagiousness 
and, as a consequence, faster human-to-human transmis­
sion. Namely abovementioned features contributed to the 
spread of the SARS-CoV-2 virus to all continents, causing 
the global COVID-2019 pandemic [1, 6].
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The epidemiological situation regarding COVID-2019 is 
constantly changing. If previously it was thought that the 
virus mainly affects people in China and neighbouring coun­
tries, today the leaders in the incidence of coronavirus are the 
United States and Brazil. Moreover, the mortality rate varies 
significandy in different countries. Thus, countries with low 
testing capacity, imperfect health care systems, and lack of 
clear emergency behaviour strategies show significantly 
higher mortality rates than COVID-2019 [5,7].
Statistical data concerning the presence of antibodies 
to SARS-CoV-2, collected from different countries, differ 
significantly not only from each other but also within one 
country at different times. After all, when analyzing WHO 
reports, patients with mild COVID-2019 have almost no 
IgG for coronavirus. Whilst in severe forms of the disease 
immunoglobulins disappear on average within 3-4 months. 
It should be noted that the genetic relatedness of different 
types of CoVs also negatively affects the determination of 
antibody levels in patients due to the frequent development 
of cross-reactions [5, 8].
That is why, on the way to overcoming the pandemic that 
engulfed humanityin 2020, the strategic vector is to monitor 
the formation of population immunity among re-convales­
cents and the development of an effective vaccine [5].
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T H E  A IM
The aim of this study was to analyze epidemiological data 
on the detection of immunoglobulins of class M and G 
(IgM, IgG) to SARS-CoV-2 among urban and rural pop­
ulation of Poltava region.
M A TE R IA LS  A N D  M E T H O D S
We have analyzed the research results of 2841 patients to 
determine IgM and IgG levels to SARS-CoV-2. The study 
was conducted using ELISA kits for qualitative detection 
of antibodies of IgM and IgG classes to SARS-CoV-2 virus 
(EQUI SARS-CoV-2 IgM, IgG), produced by EKVITEST- 
LAB LLC, Ukraine. The evaluation of the results was per­
formed according to the index of positivity of the sample 
(IP), the value of which is more than 1.1 was defined as a 
positive result.
The study included the results of patients in Poltava and 
nearby villages of Poltava region, obtained during July -  
December 2020.
In order to determine the epidemiological data on the 
detection of IgM and IgG to SARS-CoV-2 among urban 
and rural population of Poltava region, patients were di­
vided by place of residence (city, village), sex, and detection 
of immunoglobulins in the study.
The results were provided by a private certified laboratory 
in Poltava while maintaining the confidentiality of patients’ 
personal data.
The studies have been carried out in accordance with the 
Helsinki Declaration of the World Medical Association 
on the ethical principles of medical research with human 
participation. The study protocol was approved by the Bio­
ethics Committee of the Ukrainian Medical Stomatological 
Academy, Poltava, Ukraine.
The obtained data were subjected to statistical process­
ing using the standard program SPSS 16.0 software (IBM, 
Armonk, NY, USA) and expressed as the arithmetic mean 
(M) and the arithmetic mean error (± m). The presence of 
differences between the indicators of the studied groups of 
patients was assessed by Student’s t-test. The results were 
considered reliable at p <0.05.
RESULTS
As a result of the study, it was found that during the sum­
mer-autumn period of 2020, a study to detect total anti­
bodies (IgM, IgG) to SARS-CoV-2 among urban and rural 
population of Poltava region was conducted by 6 people, 
which is 0.2% of the total number of surveyed. In spite of 
all this, no positive results were found among them.
The vast majority of studies were the results of the de­
tection of IgM in the serum of patients with the pathogen 
COVID-2019. Thus, 84% of patients applied for this study,
i.e., 2375 patients out of 2841. This confirms the greater 
demand for research to detect antibodies corresponding 
to the acute period of the disease. It should be noted that 
the vast majority of people (2185, 77%) were residents of 
Poltava and only 190 (7%) patients were from rural areas.
We have found only 135 positive results for the detec­
tion of IgM to SARS-CoV-2, which was 5.7% of the total 
number of people who underwent this study from July 
to December 2020. Moreover, women received a positive 
result 1.7 times more often than men (85 and 50 people, 
respectively). In addition, the frequency of negative IgM 
results for the pathogen COVID-2019 was 94.3%, but in 
this case, on the contrary -  women received a negative re­
sult 1.5 times more often than men. The IP samples for the 
detection of IgM to SARS-CoV-2 in the serum of patients 
did not exceed 9.53 and averaged 2.5 ± 1.04.
Analyzing seasonal prevalence, we have found an in­
crease in the incidence of IgM to SARS-CoV-2 during Oc­
tober -  December by 8 times compared to July-September.
As a result of the study, it was found that patients went 
to the laboratory to detect IgG to SARS-CoV-2, 5 times 
less often (468 people), with the vast majority (445, 95%) 
among them were residents of Poltava. However, in this 
case the share of positive results was 47.7%, among which 
the female population (170,76.2%) outnumbered the male 
3.2 times. In turn, among the 245 negative IgG results to 
the pathogen COVID-2019,132 were obtained from men. 
That is, in this case, males were 1.2 times more likely to 
go to the laboratory for IgG, compared with women. In­
terestingly, the maximum IP for the detection of IgG to 
SARS-CoV-2 in the serum of patients did not exceed 8.0 
and averaged 6.05 ± 1.95.
The frequency of IgG detection to SARS-CoV-2 during 
October-December 2020 increased 17.5 times compared 
to July-September of the same year.
D IS C U S S IO N
Unconditionally, city residents applied to the laboratory 
more often to detect antibodies against coronavirus disease, 
which can be explained by both logistics difficulties (the 
need to move to the city or transportation the material in 
case of absence of a laboratory in the village) and financial 
problems.
From the obtained results, it is evidently seen that women 
turned to the laboratory for the detection of IgM antibodies 
to SARS-CoV-2 more often. For all that the vast majority 
of them received negative results. It indicates a higher 
level of anxiety, which develops against the background of 
stress in women compared to men. It is considered that 
this may be due to the neurophysiological characteristics 
of women associated with the relationship of low activity 
of enzymes that regulate catecholamine mediator systems 
and instability under stress [9,10].
In their turn, men were more often interested in detecting 
IgG to SARS-CoV-2, which indicates a disease. According 
to the research, males have a more stable level of anxiety 
and resilience in stressful situations, so the search for late 
antibodies was aimed at confirming the probable asymp­
tomatic transmission of the disease. Due to our studies, the 
frequency of negative results among men was high [9,10].
It should be noted that the number of positive results 
for IgM and IgG in general to SARS-CoV-2 during July -
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September was significantly lower than in October -  De­
cember. On the one hand, such a result could be influenced 
by weather conditions, noticing the warm beginning of 
autumn in Ukraine. After all, COVID-2019 belongs to the 
diseases that is transmitted by airborne droplets and often 
develops at low ambient temperatures.
However, on the other hand -  analyzing the quarantine 
measures to prevent the spread of coronavirus in Ukraine 
during this period, we can trace a certain trend. Thus, 
during the summer there was a weakening of preventive 
measures, which contributed to the return of pupils and 
students to educational institutions on September 1, and 
employees -  in offices and businesses. Moreover, on Sep­
tember 23, Poltava and its citizens celebrated the Day of 
Liberation of the city in the Second World War with active 
mass events. Given the data on the incubation period 
COVID-2019, it becomes quite natural to develop the peak 
incidence since October.
C O N C L U S IO N S
Thus, residents of Poltava and surrounding villages more 
often turn to laboratories to detect IgM to SARS-CoV-2, 
with mostly negative results.
The frequency of detection of positive results on IgM 
to SARS-CoV-2 is about 6%. The share of positive results 
on IgG to SARS-CoV-2 was 47.7%, among them 76.2% 
were women.
The frequency of detection of IgM and IgG to SARS- 
CoV-2 during October-December 2020 significantly 
exceeds the indices in July-September of the same year.
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